English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2287]
News [5243]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
IKZF1 mutations associated with paediatric ALL
Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA
IKZF1 mutations associated with paediatric ALL ( Dr Michelle Churchman - St. Jude Children's Research Hospital, Memphis, USA )
5 Dec 2016
ALL: Combining paediatric-type therapy with minimal residual disease
Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
ALL: Combining paediatric-type therapy with minimal residual disease ( Dr Alessandro Rambaldi - Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy )
5 Dec 2016
ASH 2016: AML, CLL and leukaemogenesis latest
Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA
ASH 2016: AML, CLL and leukaemogenesis latest ( Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Venetoclax plus cytarabine in elderly AML patients
Dr Andrew Wei - Alfred Hospital, Melbourne, Australia
Venetoclax plus cytarabine in elderly AML patients ( Dr Andrew Wei - Alfred Hospital, Melbourne, Australia )
4 Dec 2016
Remissions following anti-CD22 CAR therapy in children with relapsed ALL
Dr Terry Fry - National Cancer Institute, Bethesda, USA
Remissions following anti-CD22 CAR therapy in children with relapsed ALL ( Dr Terry Fry - National Cancer Institute, Bethesda, USA )
3 Dec 2016
Mutational drivers of thyroid cancer
Dr Alexsandr Lavrov - N.I.Pirogov Russian National Research Medical University...
Mutational drivers of thyroid cancer ( Dr Alexsandr Lavrov - N.I.Pirogov Russian National Research Medical University, Moscow, Russia )
24 Nov 2016
Gold nanoparticles and cancer treatment
Bas Bavelaar - University of Oxford, Oxford, UK
Gold nanoparticles and cancer treatment ( Bas Bavelaar - University of Oxford, Oxford, UK )
23 Nov 2016
Towards delivering truly personalised therapy for oesophageal cancer
Prof Tim Underwood - University of Southampton, Southampton, UK
Towards delivering truly personalised therapy for oesophageal cancer ( Prof Tim Underwood - University of Southampton, Southampton, UK )
23 Nov 2016
Improving the evidence base for symptom control
Prof David Currow - Flinders University, Adelaide, Australia
Improving the evidence base for symptom control ( Prof David Currow - Flinders University, Adelaide, Australia )
23 Nov 2016
Highlights of the SIOG posterwalk
Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus
Highlights of the SIOG posterwalk ( Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus )
22 Nov 2016
Advancements in the field of geriatric oncology
Dr Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA
Advancements in the field of geriatric oncology ( Dr Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA )
22 Nov 2016
Closing poll on CDK inhibition in advanced breast cancer with failing...
Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy
Closing poll on CDK inhibition in advanced breast cancer with failing antiestrogens ( Dr Carmen Criscitiello - Istituto Europeo di Oncologia, Milan, Italy )
15 Nov 2016
<1...120121122123124...191>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top